Revised Drug Administration Law and Its Broader Impact
On 26 August 2019, the Standing Committee of the National People’s Congress approved the revised Drug Administration Law (DAL). The revised DAL will come into effect on 1 December, 2019. New rules addressing market demands and social issues were incorporated into the comprehensive revision. Notably, these changes aim at rewarding drug innovation and discouraging misconduct.